Company
Headquarters: Wan Chai, Hong Kong
Employees: 745
CEO: Mr. Fei Chen
HK$7.59 Billion
HKD as of July 1, 2024
US$972.0 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates in three segments: Hong Kong, PRC, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 71 retail outlets in 20 countries and regions. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wanchai, Hong Kong. Beijing Tong Ren Tang Chinese Medicine Company Limited is a subsidiary of Tong Ren Tang Technologies Co., Ltd.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Beijing Tong Ren Tang Chinese Medicine Co Ltd has the following listings and related stock indices.
Stock: HKEX: 3613 wb_incandescent
Stock: FSX: TQR wb_incandescent